Ithemba Labs

What Ithemba Labs does

iThemba Laboratories for Accelerator-Based Science (LABS) is a South African national research facility operating as a business unit of the National Research Foundation (NRF) under the Department of Science and Innovation. Headquartered in Faure, Western Cape, with a secondary Gauteng campus in Johannesburg, the facility runs Africa's largest cluster of particle accelerators, anchored by the 200-MeV Separated Sector Cyclotron (SSC) and supplemented by a 3-MV Tandetron, a 6-MV Tandem accelerator, the Accelerator Mass Spectrometry (AMS) facility, the GAMKA gamma-ray spectrometer, and the AFRODITE detector array.

The facility serves three primary user communities: nuclear medicine (production and distribution of radiopharmaceuticals to 80+ national public and private nuclear medicine departments and ~100 international clients), nuclear physics research (fundamental and applied, including nuclear reactions, nuclear structure, nuclear astrophysics, neutron metrology, and radiation damage studies), and applied materials/environmental analysis (PIXE, RBS, ERDA, XRD, AFM, and radio-carbon dating). Recent infrastructure additions — the 2023 South African Isotope Facility (SAIF), a dedicated medical cyclotron, and the Technology Innovation Platform (TIP) — have separated isotope production from research beam time and opened a commercialization channel for detector technology. Human capacity development is centralized under SAINTS, while international engagement runs through long-standing SA-CERN (since 2008) and SA-JINR (20+ years) programmes and a 2025 trilateral with INRS (Quebec).

The revenue model is hybrid but government-dominated: baseline funding flows through NRF/DSI appropriations, with incremental revenue from commercial isotope and radiopharmaceutical sales and from research services rendered to universities and industrial clients (e.g., mining sector environmental monitoring). Pricing is not publicly disclosed; services are provided through research agreements and institutional collaborations rather than standard commercial terms. The customer base spans healthcare providers, academic and research institutions, students and early-career researchers, and mining/environmental agencies — with the South African government acting as the de facto anchor funder.

Name

Ithemba Labs

Legal name

iThemba Laboratories for Accelerator-Based Science

Website

https://tlabs.ac.za

Company type

Private

Founded year

1987

Operating status

Operating

Headcount range

251–500 employees

Short description

iThemba LABS is South Africa's national accelerator-based science facility under the NRF, operating particle accelerators in Cape Town and Johannesburg to produce medical radioisotopes, conduct nuclear physics research, and train scientists across Africa.

Ownership category

akta.pro rank

Product category

Nuclear Research and Isotope Production Services

NAICS

Irradiation Apparatus Manufacturing (334517), Medical and Diagnostic Laboratories (62151), Analytical Laboratory Instrument Manufacturing (334516)

SIC

Laboratory Analytical Instruments (3826), Services-Commercial Physical & Biological Research (8731), Industrial Instruments For Measurement, Display, And Control (3823)

akta.pro primary industry

Radioisotope Production (Reactor/Cyclotron/Gamma) (HLAIAGAD)

akta.pro secondary industries

Medical Radioisotope Production (Reactor/Cyclotron, Mo-99/Tc-99m, I-131, Lu-177, etc.) (EUAKAIAA), Radiation Detection Instruments & Systems (Portal monitors, spectrometers, contamination monitors) (EUAKAIAK), Research & Test Reactor Operations (Non-Commercial Power) (EUACADAH), Nuclear Medicine Clinical Services & Therapy Centers (HLAIAGAI)

Keywords

• Nuclear physics research
• Medical isotope production
• Radiopharmaceutical supply
• Particle accelerator services
• Materials analysis

Headquarters

HQ city

Somerset West

HQ country

South Africa

HQ region

Africa

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Infrastructure, Operations, Supply Chain

Revenue model

1. Government Funding (NRF): As a business unit of the National Research Foundation (NRF), iThemba LABS receives government funding for operations, infrastructure maintenance, and research programs.
2. Nuclear Medicine and Isotope Sales: Production and sale of medical radioisotopes for diagnostics, imaging, and therapy. Supplies radiopharmaceuticals to over 80 national public and private nuclear medicine departments and longer half-life radionuclide products to nearly 100 international clients.
3. Research Services and Training: Provides research infrastructure access, training programs, and specialized services to academic institutions, researchers, and students through partnerships with universities.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

iThemba LABS operates particle accelerators including the 200-MeV Separated Sector Cyclotron (SSC) for nuclear physics research and isotope production. It produces and supplies medical radioisotopes and radiopharmaceuticals to over 80 national nuclear medicine departments and nearly 100 international clients. The facility also provides accelerator-based research infrastructure access, training programs, and specialized materials analysis services to academic, research, and industry clients.

Product overview

iThemba LABS operates as a unified research facility providing accelerator-based science services through multiple integrated components. The core offering centers on the 200-MeV Separated Sector Cyclotron (SSC) for nuclear physics and isotope production, complemented by the South African Isotope Facility (SAIF) for dedicated medical isotope production. Supporting infrastructure includes the Tandetron Laboratory for materials research and the AMS Facility for isotope analysis. Training and development is consolidated under SAINTS, while international collaboration is facilitated through SA-CERN and SA-JINR programmes. The facility also hosts GAMKA gamma-ray spectrometer and the Technology Innovation Platform (TIP) for commercialization. Together these products form a comprehensive ecosystem for accelerator-based research, isotope production, and human capacity development in nuclear sciences across Africa.

Differentiator

Problem solved

Functional benefit

Products and services

• Nuclear Medicine and Isotope Production Produces medical radioisotopes used in diagnostics, imaging, and therapy. Supplies radiopharmaceuticals to more than 80 national public and private nuclear medicine departments and longer half-life radionuclide products to nearly 100 international clients.
• Basic and Applied Nuclear Physics Research Provides laboratories for nuclear physics experiments including Nuclear Reactions, Nuclear Structure, Nuclear Astrophysics, neutron metrology, and radiation damage studies. Features the K=600 magnetic spectrometer and AFRODITE gamma-ray detector array.
• Tandetron Laboratory Features a 3-MV Tandetron accelerator dedicated to materials research with capabilities for ion beam analysis (IBA), including PIXE, RBS, ERDA, XRD, and AFM techniques. Also hosts a low-energy nuclear astrophysics beamline for proton capture reaction studies.
• Accelerator Mass Spectrometry (AMS) Facility State-of-the-art facility for isotope analysis with applications in climate change, archaeology, and cultural heritage studies. Located at the Johannesburg (Gauteng) campus.
• South African Isotope Facility (SAIF) Established in 2023, SAIF enables isotope production for medical, industrial, and research purposes, freeing up beam time on the SSC for fundamental and applied nuclear physics research.
• Southern African Institute for Nuclear Technology and Sciences (SAINTS) Training and development platform offering postgraduate student training, workshops, summer schools, and vocational programmes in accelerator-based science, nuclear sciences, materials science, radiation protection, radiochemistry, and AI/ML.
• SA-CERN Programme Provides South African research scientists, engineers, and students with access to CERN's Large Hadron Collider facilities in Geneva, Switzerland, and leverages technology transfer opportunities through participation in the ATLAS experiment.
• SA-JINR Programme

Named customers4 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

Eight partnerships are on record, tiered core, minor and major.

• INRS (Institut national de la recherche scientifique)coreStrategic or Co-development Partner · 1 November 2025Strategic partnership signed between INRS, University of South Africa, and iThemba LABS to enhance scientific and academic collaboration between Quebec and South Africa. Focuses on joint research, shared infrastructure, and researcher/student mobility.
• Vaal University of Technology (VUT)minorStrategic or Co-development Partner · 1 January 2024VUT visited iThemba LABS to explore collaboration opportunities for student training and staff development within accelerator-based sciences. A Memorandum of Agreement is being considered.
• NMISA (National Metrology Institute of South Africa)majorStrategic or Co-development Partner · 1 January 2015Agreement signed nominating iThemba LABS as a designated facility for medium- and high-energy neutron measurements. Series of upgrades resulted in the neutron facility meeting requirements of a high-energy neutron metrology facility in 2020.
• UNESCO and UNISAcoreStrategic or Co-development Partner · 1 January 2013UNESCO-UNISA Africa Chair in Nanoscience and Nanotechnology established through trilateral collaboration. Oversees training and mentoring of early-career scientists and postgraduates in nanoscience, nanotechnology, and innovation.
• NTP (Pty) LtdcoreStrategic or Co-development Partner · 1 January 2012Collaboration with NTP (Pty) Ltd, a subsidiary of NECSA, for the inauguration of an 11-MeV cyclotron dedicated to production of 18F (fluorodeoxyglucose) for nuclear medicine, enabling delivery to the South African nuclear medicine community.
• CERN (European Centre for Nuclear Research)coreStrategic or Co-development Partner · 1 January 2008iThemba LABS is the institutional host of the SA-CERN Programme, linking South Africa to CERN's Large Hadron Collider. The programme provides access to CERN facilities for South African scientists, engineers, and students, and contributes to the ATLAS experiment. Collaborating universities include UCT, Wits, UKZN, and Johannesburg.
• JINR (Joint Institute for Nuclear Research)coreStrategic or Co-development Partner20-year partnership through the SA-JINR programme. Includes student exchange, summer schools, joint research projects, and the recently established JINR Information Centre at iThemba LABS. More than 20 projects covering research thematic areas at JINR.
• National University of Singapore (CIBA)minorStrategic or Co-development PartnerDr Yanxin Dou from NUS visited to work with iThemba LABS scientists on reducing the nuclear microprobe spot size to less than 1µm², a first for Africa.

Scale indicators5 records

Recent moves10 records

Expansion highlights6 records

Broad incumbents

• Joint Institute for Nuclear Research (JINR): International nuclear physics laboratory in Dubna, Russia, with whom iThemba LABS has maintained a 20-year strategic partnership. Operates a comparable mix of fundamental nuclear physics, detector development, and training programmes that mirror iThemba LABS' SAINTS and GAMKA activities.
• Curium Pharma: Global commercial radiopharmaceutical manufacturer and distributor. Curium competes in the same international longer half-life radionuclide market where iThemba LABS supplies ~100 international customers, making it a commercial comparable in the isotope revenue stream.
• Nuclear Energy Corporation of South Africa (NECSA): State-owned nuclear entity that houses the Safari-1 research reactor and the NTP radioisotope subsidiary. NECSA is the South African national nuclear authority under which iThemba LABS' isotope supply ecosystem operates, making it a structural peer and parent of the most direct local competitor.

Direct peers

• TRIUMF: Canada's particle accelerator centre operates a comparable model of government-funded fundamental nuclear physics research combined with commercial-scale medical isotope production. Overlaps directly with iThemba LABS on cyclotron-based isotope supply and proton/particle therapy history.
• LNL INFN (Legnaro National Laboratories): Italian national accelerator laboratory operating tandem accelerators and superconducting LINAC for nuclear structure and applied research. The use of Tandem/Tandetron accelerators and ion beam analysis capabilities maps directly onto iThemba LABS' Western Cape and Gauteng facilities.
• Australian Nuclear Science and Technology Organisation (ANSTO): ANSTO operates the OPAL research reactor and produces medical radioisotopes for domestic and export markets, combining fundamental nuclear research with a commercial radiopharmaceutical business — the same dual model that defines iThemba LABS.
• NTP Radioisotopes (Pty) Ltd: South African subsidiary of NECSA and direct in-country peer and partner of iThemba LABS in radioisotope production. NTP co-inaugurated the 11-MeV cyclotron for 18F production at iThemba LABS and is the primary local competitor in radiopharmaceutical supply.
• Paul Scherrer Institute (PSI): Swiss national lab operating high-power cyclotrons for fundamental nuclear physics and large-scale medical isotope production. Closely comparable in scope, funding model, and product mix to iThemba LABS' SSC and dedicated cyclotron operations.
• GANIL (Grand Accélérateur National d'Ions Lourds): French national heavy-ion accelerator facility with a research portfolio covering nuclear structure, nuclear reactions, and nuclear astrophysics — directly mirroring iThemba LABS' SSC-based BASIC SCIENCE programme and use of detector arrays like AFRODITE and GAMKA.

Regional players

• Variable Energy Cyclotron Centre (VECC): Indian national accelerator facility operating cyclotrons for nuclear physics research and medical radioisotope production. Comparable in scale and mandate to iThemba LABS as a government-funded emerging-market accelerator laboratory.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/iThembaLABSCape

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles16 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ithemba Labs